Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 32 of 32 entries
Sorted by: Best Match Show Resources per page
Author Correction: Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's disease.

Nature communications

Krashia P, Cordella A, Nobili A, La Barbera L, Federici M, Leuti A, Campanelli F, Natale G, Marino G, Calabrese V, Vedele F, Ghiglieri V, Picconi B, Di Lazzaro G, Schirinzi T, Sancesario G, Casadei N, Riess O, Bernardini S, Pisani A, Calabresi P, Viscomi MT, Serhan CN, Chiurchiù V, D'Amelio M, Mercuri NB.
PMID: 31611555
Nat Commun. 2019 Oct 14;10(1):4725. doi: 10.1038/s41467-019-12538-2.

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Cite
Krashia P, Cordella A, Nobili A, et al. Author Correction: Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's disease. Nat Commun. 2019;10(1):4725doi: 10.1038/s41467-019-12538-2.
Krashia, P., Cordella, A., Nobili, A., La Barbera, L., Federici, M., Leuti, A., Campanelli, F., Natale, G., Marino, G., Calabrese, V., Vedele, F., Ghiglieri, V., Picconi, B., Di Lazzaro, G., Schirinzi, T., Sancesario, G., Casadei, N., Riess, O., Bernardini, S., Pisani, A., Calabresi, P., Viscomi, M. T., Serhan, C. N., Chiurchiù, V., D'Amelio, M., & Mercuri, N. B. (2019). Author Correction: Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's disease. Nature communications, 10(1), 4725. https://doi.org/10.1038/s41467-019-12538-2
Krashia, Paraskevi, et al. "Author Correction: Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's disease." Nature communications vol. 10,1 (2019): 4725. doi: https://doi.org/10.1038/s41467-019-12538-2
Krashia P, Cordella A, Nobili A, La Barbera L, Federici M, Leuti A, Campanelli F, Natale G, Marino G, Calabrese V, Vedele F, Ghiglieri V, Picconi B, Di Lazzaro G, Schirinzi T, Sancesario G, Casadei N, Riess O, Bernardini S, Pisani A, Calabresi P, Viscomi MT, Serhan CN, Chiurchiù V, D'Amelio M, Mercuri NB. Author Correction: Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's disease. Nat Commun. 2019 Oct 14;10(1):4725. doi: 10.1038/s41467-019-12538-2. PMID: 31611555; PMCID: PMC6791874.
Copy Download .nbib Format: NLM
Severe COVID-19 Complicated by Cerebral Venous Thrombosis in a Newborn Successfully Treated with Remdesivir, Glucocorticoids, and Hyperimmune Plasma.

International journal of environmental research and public health

Cursi L, Calo Carducci FI, Chiurchiu S, Romani L, Stoppa F, Lucignani G, Russo C, Longo D, Perno CF, Cecchetti C, Lombardi MH, D'Argenio P, Lancella L, Bernardi S, Rossi P.
PMID: 34948814
Int J Environ Res Public Health. 2021 Dec 15;18(24). doi: 10.3390/ijerph182413201.

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for the coronavirus disease 2019 (COVID-19) pandemic, affecting all age groups with a wide spectrum of clinical presentation ranging from asymptomatic to severe interstitial pneumonia, hyperinflammation, and death. Children and infants...

Cite
Cursi L, Calo Carducci FI, Chiurchiu S, et al. Severe COVID-19 Complicated by Cerebral Venous Thrombosis in a Newborn Successfully Treated with Remdesivir, Glucocorticoids, and Hyperimmune Plasma. Int J Environ Res Public Health. 2021;18(24)doi: 10.3390/ijerph182413201.
Cursi, L., Calo Carducci, F. I., Chiurchiu, S., Romani, L., Stoppa, F., Lucignani, G., Russo, C., Longo, D., Perno, C. F., Cecchetti, C., Lombardi, M. H., D'Argenio, P., Lancella, L., Bernardi, S., & Rossi, P. (2021). Severe COVID-19 Complicated by Cerebral Venous Thrombosis in a Newborn Successfully Treated with Remdesivir, Glucocorticoids, and Hyperimmune Plasma. International journal of environmental research and public health, 18(24), . https://doi.org/10.3390/ijerph182413201
Cursi, Laura, et al. "Severe COVID-19 Complicated by Cerebral Venous Thrombosis in a Newborn Successfully Treated with Remdesivir, Glucocorticoids, and Hyperimmune Plasma." International journal of environmental research and public health vol. 18,24 (2021). doi: https://doi.org/10.3390/ijerph182413201
Cursi L, Calo Carducci FI, Chiurchiu S, Romani L, Stoppa F, Lucignani G, Russo C, Longo D, Perno CF, Cecchetti C, Lombardi MH, D'Argenio P, Lancella L, Bernardi S, Rossi P. Severe COVID-19 Complicated by Cerebral Venous Thrombosis in a Newborn Successfully Treated with Remdesivir, Glucocorticoids, and Hyperimmune Plasma. Int J Environ Res Public Health. 2021 Dec 15;18(24). doi: 10.3390/ijerph182413201. PMID: 34948814.
Copy Download .nbib Format: NLM
[ABO incompatible living donor kidney transplantation in a center in Córdoba, Argentina].

Medicina

Borgogno P, Fernández P, Douthat W, de Arteaga J, Damonte JC, Giacomi V, de la Fuente J, Chiurchiu C.
PMID: 34875598
Medicina (B Aires). 2021;81(6):986-995.

The ABO incompatible (ABOi) living donor (LD) kidney transplant allows increasing the number of donors and reducing the time on the waiting list. The objectives of this study were to compare graft survival, patient survival, rejection risk factors and...

Cite
Borgogno P, Fernández P, Douthat W, et al. Trasplante renal donante vivo ABO incompatible en un centro de Córdoba, Argentina. [ABO incompatible living donor kidney transplantation in a center in Córdoba, Argentina]. Medicina (B Aires). 2021;81(6):986-995
Borgogno, P., Fernández, P., Douthat, W., de Arteaga, J., Damonte, J. C., Giacomi, V., de la Fuente, J., & Chiurchiu, C. (2021). Trasplante renal donante vivo ABO incompatible en un centro de Córdoba, Argentina. [ABO incompatible living donor kidney transplantation in a center in Córdoba, Argentina]. Medicina, 81(6), 986-995.
Borgogno, Pamela, et al. "Trasplante renal donante vivo ABO incompatible en un centro de Córdoba, Argentina." [ABO incompatible living donor kidney transplantation in a center in Córdoba, Argentina]. Medicina vol. 81,6 (2021): 986-995.
Borgogno P, Fernández P, Douthat W, de Arteaga J, Damonte JC, Giacomi V, de la Fuente J, Chiurchiu C. Trasplante renal donante vivo ABO incompatible en un centro de Córdoba, Argentina. [ABO incompatible living donor kidney transplantation in a center in Córdoba, Argentina]. Medicina (B Aires). 2021;81(6):986-995. Spanish. PMID: 34875598.
Copy Download .nbib Format: NLM
Thermodynamics of slow solutions to the gas-piston equations.

Physical review. E

Gubbiotti G, Chiuchiù D.
PMID: 27841498
Phys Rev E. 2016 Oct;94(4):042106. doi: 10.1103/PhysRevE.94.042106. Epub 2016 Oct 07.

Despite its historical importance, a perfect gas enclosed by a pistons and in contact with a thermal reservoirs is a system still largely under study. Its thermodynamic properties are not yet well understood when driven under nonequilibrium conditions, and...

Cite
Gubbiotti G, Chiuchiù D. Thermodynamics of slow solutions to the gas-piston equations. Phys Rev E. 2016;94(4):042106doi: 10.1103/PhysRevE.94.042106.
Gubbiotti, G., & Chiuchiù, D. (2016). Thermodynamics of slow solutions to the gas-piston equations. Physical review. E, 94(4), 042106. https://doi.org/10.1103/PhysRevE.94.042106
Gubbiotti, G, and Chiuchiù, D. "Thermodynamics of slow solutions to the gas-piston equations." Physical review. E vol. 94,4 (2016): 042106. doi: https://doi.org/10.1103/PhysRevE.94.042106
Gubbiotti G, Chiuchiù D. Thermodynamics of slow solutions to the gas-piston equations. Phys Rev E. 2016 Oct;94(4):042106. doi: 10.1103/PhysRevE.94.042106. Epub 2016 Oct 07. PMID: 27841498.
Copy Download .nbib Format: NLM
Severe COVID-19 Complicated by Cerebral Venous Thrombosis in a Newborn Successfully Treated with Remdesivir, Glucocorticoids, and Hyperimmune Plasma.

International journal of environmental research and public health

Cursi L, Calo Carducci FI, Chiurchiu S, Romani L, Stoppa F, Lucignani G, Russo C, Longo D, Perno CF, Cecchetti C, Lombardi MH, D'Argenio P, Lancella L, Bernardi S, Rossi P.
PMID: 34948814
Int J Environ Res Public Health. 2021 Dec 15;18(24). doi: 10.3390/ijerph182413201.

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for the coronavirus disease 2019 (COVID-19) pandemic, affecting all age groups with a wide spectrum of clinical presentation ranging from asymptomatic to severe interstitial pneumonia, hyperinflammation, and death. Children and infants...

Cite
Cursi L, Calo Carducci FI, Chiurchiu S, et al. Severe COVID-19 Complicated by Cerebral Venous Thrombosis in a Newborn Successfully Treated with Remdesivir, Glucocorticoids, and Hyperimmune Plasma. Int J Environ Res Public Health. 2021;18(24)doi: 10.3390/ijerph182413201.
Cursi, L., Calo Carducci, F. I., Chiurchiu, S., Romani, L., Stoppa, F., Lucignani, G., Russo, C., Longo, D., Perno, C. F., Cecchetti, C., Lombardi, M. H., D'Argenio, P., Lancella, L., Bernardi, S., & Rossi, P. (2021). Severe COVID-19 Complicated by Cerebral Venous Thrombosis in a Newborn Successfully Treated with Remdesivir, Glucocorticoids, and Hyperimmune Plasma. International journal of environmental research and public health, 18(24), . https://doi.org/10.3390/ijerph182413201
Cursi, Laura, et al. "Severe COVID-19 Complicated by Cerebral Venous Thrombosis in a Newborn Successfully Treated with Remdesivir, Glucocorticoids, and Hyperimmune Plasma." International journal of environmental research and public health vol. 18,24 (2021). doi: https://doi.org/10.3390/ijerph182413201
Cursi L, Calo Carducci FI, Chiurchiu S, Romani L, Stoppa F, Lucignani G, Russo C, Longo D, Perno CF, Cecchetti C, Lombardi MH, D'Argenio P, Lancella L, Bernardi S, Rossi P. Severe COVID-19 Complicated by Cerebral Venous Thrombosis in a Newborn Successfully Treated with Remdesivir, Glucocorticoids, and Hyperimmune Plasma. Int J Environ Res Public Health. 2021 Dec 15;18(24). doi: 10.3390/ijerph182413201. PMID: 34948814; PMCID: PMC8701660.
Copy Download .nbib Format: NLM
Potent T cell-mediated anti-inflammatory role of the selective CB2 agonist lenabasum in multiple sclerosis.

Neuropathology and applied neurobiology

Tiberi M, Evron T, Saracini S, Boffa L, Mercuri NB, Chintalacharuvu SR, Atamas SP, Chiurchiù V.
PMID: 34543449
Neuropathol Appl Neurobiol. 2021 Sep 20; doi: 10.1111/nan.12768. Epub 2021 Sep 20.

BACKGROUND: Lenabasum is a synthetic cannabinoid receptor type-2 (CB2) agonist able to exert potent anti-inflammatory effects, but its role on T cells remains unknown.OBJECTIVES: The present study was undertaken to investigate anti-inflammatory mechanisms of lenabasum in T lymphocyte subsets...

Cite
Tiberi M, Evron T, Saracini S, et al. Potent T cell-mediated anti-inflammatory role of the selective CB2 agonist lenabasum in multiple sclerosis. Neuropathol Appl Neurobiol. 2021;doi: 10.1111/nan.12768.
Tiberi, M., Evron, T., Saracini, S., Boffa, L., Mercuri, N. B., Chintalacharuvu, S. R., Atamas, S. P., & Chiurchiù, V. (2021). Potent T cell-mediated anti-inflammatory role of the selective CB2 agonist lenabasum in multiple sclerosis. Neuropathology and applied neurobiology, . https://doi.org/10.1111/nan.12768
Tiberi, Marta, et al. "Potent T cell-mediated anti-inflammatory role of the selective CB2 agonist lenabasum in multiple sclerosis." Neuropathology and applied neurobiology vol. (2021). doi: https://doi.org/10.1111/nan.12768
Tiberi M, Evron T, Saracini S, Boffa L, Mercuri NB, Chintalacharuvu SR, Atamas SP, Chiurchiù V. Potent T cell-mediated anti-inflammatory role of the selective CB2 agonist lenabasum in multiple sclerosis. Neuropathol Appl Neurobiol. 2021 Sep 20; doi: 10.1111/nan.12768. Epub 2021 Sep 20. PMID: 34543449.
Copy Download .nbib Format: NLM
Characterization of a natural variant of human NDP52 and its functional consequences on mitophagy.

Cell death and differentiation

Di Rita A, Angelini DF, Maiorino T, Caputo V, Cascella R, Kumar M, Tiberti M, Lambrughi M, Wesch N, Löhr F, Dötsch V, Carinci M, D'Acunzo P, Chiurchiù V, Papaleo E, Rogov VV, Giardina E, Battistini L, Strappazzon F.
PMID: 33723372
Cell Death Differ. 2021 Aug;28(8):2499-2516. doi: 10.1038/s41418-021-00766-3. Epub 2021 Mar 15.

The role of mitophagy, a process that allows the removal of damaged mitochondria from cells, remains unknown in multiple sclerosis (MS), a disease that is found associated with dysfunctional mitochondria. Here we have qualitatively and quantitatively studied the main...

Cite
Di Rita A, Angelini DF, Maiorino T, et al. Characterization of a natural variant of human NDP52 and its functional consequences on mitophagy. Cell Death Differ. 2021;28(8):2499-2516doi: 10.1038/s41418-021-00766-3.
Di Rita, A., Angelini, D. F., Maiorino, T., Caputo, V., Cascella, R., Kumar, M., Tiberti, M., Lambrughi, M., Wesch, N., Löhr, F., Dötsch, V., Carinci, M., D'Acunzo, P., Chiurchiù, V., Papaleo, E., Rogov, V. V., Giardina, E., Battistini, L., & Strappazzon, F. (2021). Characterization of a natural variant of human NDP52 and its functional consequences on mitophagy. Cell death and differentiation, 28(8), 2499-2516. https://doi.org/10.1038/s41418-021-00766-3
Di Rita, Anthea, et al. "Characterization of a natural variant of human NDP52 and its functional consequences on mitophagy." Cell death and differentiation vol. 28,8 (2021): 2499-2516. doi: https://doi.org/10.1038/s41418-021-00766-3
Di Rita A, Angelini DF, Maiorino T, Caputo V, Cascella R, Kumar M, Tiberti M, Lambrughi M, Wesch N, Löhr F, Dötsch V, Carinci M, D'Acunzo P, Chiurchiù V, Papaleo E, Rogov VV, Giardina E, Battistini L, Strappazzon F. Characterization of a natural variant of human NDP52 and its functional consequences on mitophagy. Cell Death Differ. 2021 Aug;28(8):2499-2516. doi: 10.1038/s41418-021-00766-3. Epub 2021 Mar 15. PMID: 33723372; PMCID: PMC8329179.
Copy Download .nbib Format: NLM
Pro-resolving lipid mediator lipoxin A.

Cell reports

Derada Troletti C, Enzmann G, Chiurchiù V, Kamermans A, Tietz SM, Norris PC, Jahromi NH, Leuti A, van der Pol SMA, Schouten M, Serhan CN, de Vries HE, Engelhardt B, Kooij G.
PMID: 34077725
Cell Rep. 2021 Jun 01;35(9):109201. doi: 10.1016/j.celrep.2021.109201.

The chronic neuro-inflammatory character of multiple sclerosis (MS) suggests that the natural process to resolve inflammation is impaired. This protective process is orchestrated by specialized pro-resolving lipid mediators (SPMs), but to date, the role of SPMs in MS remains...

Cite
Derada Troletti C, Enzmann G, Chiurchiù V, et al. Pro-resolving lipid mediator lipoxin A. Cell Rep. 2021;35(9):109201doi: 10.1016/j.celrep.2021.109201.
Derada Troletti, C., Enzmann, G., Chiurchiù, V., Kamermans, A., Tietz, S. M., Norris, P. C., Jahromi, N. H., Leuti, A., van der Pol, S. M. A., Schouten, M., Serhan, C. N., de Vries, H. E., Engelhardt, B., & Kooij, G. (2021). Pro-resolving lipid mediator lipoxin A. Cell reports, 35(9), 109201. https://doi.org/10.1016/j.celrep.2021.109201
Derada Troletti, Claudio, et al. "Pro-resolving lipid mediator lipoxin A." Cell reports vol. 35,9 (2021): 109201. doi: https://doi.org/10.1016/j.celrep.2021.109201
Derada Troletti C, Enzmann G, Chiurchiù V, Kamermans A, Tietz SM, Norris PC, Jahromi NH, Leuti A, van der Pol SMA, Schouten M, Serhan CN, de Vries HE, Engelhardt B, Kooij G. Pro-resolving lipid mediator lipoxin A. Cell Rep. 2021 Jun 01;35(9):109201. doi: 10.1016/j.celrep.2021.109201. PMID: 34077725; PMCID: PMC8491454.
Copy Download .nbib Format: NLM
Showing 25 to 32 of 32 entries